|
Market Closed -
NSE India S.E.
04:35:08 08/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 388.30 INR | +5.32% |
|
+6.42% | +340.50% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medicinal Chemicals and Botanical Products | ||||||||||
Pharmaceutical Business | 906.78Cr | 1.05TCr | 1.22TCr | 1.3TCr | 561.71Cr | |||||
Total Assets | 1.82TCr | 1.8TCr | 1.82TCr | 1.17TCr | 1.44TCr | |||||
Interest Expense | -93Cr | -91Cr | -86Cr | -47Cr | -1.38Cr | |||||
Income Tax Expense | 21Cr | 15Cr | 39Cr | 160.31Cr | 7.27Cr | |||||
CAPEX | -4.4Cr | -18Cr | -13Cr | -45Cr | -64Cr | |||||
EBT | 18Cr | 13Cr | 87Cr | 581.76Cr | 257.8Cr | |||||
D&A | 55Cr | 129.98Cr | 57Cr | 53Cr | 22Cr | |||||
Net Income | -3.15Cr | -2.15Cr | 48Cr | 420.96Cr | 250.48Cr |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Export | 672.49Cr | 796.04Cr | 937.4Cr | 1TCr | 406Cr | |||||
Total Assets | 136.32Cr | 207.35Cr | 224.71Cr | 51Cr | - | |||||
Operating Income | 253.51Cr | 288.59Cr | 375.64Cr | 450.27Cr | - | |||||
India | 218.86Cr | 242.69Cr | 269.91Cr | 278.62Cr | 155.72Cr | |||||
Total Assets | 364.95Cr | 275.14Cr | 303.64Cr | 106.6Cr | - | |||||
Operating Income | 81Cr | 86Cr | 81Cr | 104.73Cr | - | |||||
Unallocated | 23Cr | - | - | - | - | |||||
Total Assets | 1.32TCr | 1.32TCr | 1.3TCr | 1.01TCr | - |
- Stock Market
- Stocks
- INDSWFTLAB Stock
- Financials Ind-Swift Laboratories Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
